Valeant nears deal to buy Salix for about $10 billion: WSJ
By Reuters
Feb 21, 2015 05:18 PM EST
Regions
Valeant Pharmaceuticals International (VRX.TO) is near a deal to buy Salix Pharmaceuticals Ltd (SLXP.O) for about $10 billion, the Wall Street Journal reported on Saturday.
© 2024 VCPOST, All rights reserved. Do not reproduce without permission.
Join the Conversation